GLP-1 medicines in the menopause transition: honest help and risks

If you are in your 40s or early 50s and the weight has started sitting on your belly in a way it never did before, you are not imagining it. Around the menopause transition, estrogen falls, and the body changes how it stores fat, how it handles sugar, and how it looks after bone. Some women ask whether a GLP-1 medicine such as semaglutide could help. The honest answer has three parts. First, GLP-1 medicines are not hormone therapy and they do not treat menopause itself. Second, the early evidence in menopausal and postmenopausal women is real but small: these medicines do help with weight loss and belly fat, and they may help cardiometabolic risk. Third, the menopause-specific data on bone and muscle are still limited, so the protective habits, protein, strength work, and bone care, matter even more while on them. This guide keeps the focus on the medicine in this life-stage, not on menopause biology overall, which has its own article. Please talk to your doctor about your own symptoms, hormone therapy, and bone risk. Nothing here is a prescription.